Your answer Was Incorrect
NEUROSAE 2018 ANNUAL MEETING EDITION (VOLUME 10, ISSUE 3)
QUESTION 49 OF 100
Which of the following patients with Parkinson’s disease is at highest risk of developing an impulse control disorder from direct dopamine agonist therapy?
A. A 38-year-old woman
B. A 38-year-old man
C. A 67-year-old woman
D. An 85-year-old woman
E. An 85-year-old man **
** = Your answer
Impulse control disorders are some of the most important potential adverse effects of dopamine agonists, such as pramipexole or ropinirole, and can result in significant harm physically, socially, and financially. Patients and their families need to be counseled about these risks and should be monitored for evidence of problems at regular follow-up visits. Younger men are at highest risk for this complication of therapy, and patients with a history of substance abuse or other problems with addiction also may be at risk.
* Goldman JG. Neuropsychiatric issues in Parkinson disease. Continuum Lifelong Learning Neurol. 2016;22(4):1086-1103.